Study directory

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Back to overview
9138studies shown
Showing 4,753-4,764 of 9,138
Other study type icon
CompletedNCT04624243

Elpipodect for schizophrenia

This study is completed in the United States, in Bulgaria, in Croatia, .... It is testing elpipodect for schizophrenia.

Multiple locations, including Bentonville
SchizophreniaOtherFrom 18 Years to 55 Years
Countries
United States, Bulgaria, Croatia, ...
Sponsor
Merck Sharp & Dohme LLC
Condition
Schizophrenia
Drug study icon
Active Not RecruitingNCT06608641

Endoxifen for Bipolarity

This study is active but not recruiting in the United States. It is testing endoxifen for Bipolarity.

Multiple locations, including Cerritos
BipolarityDrugA study involving a medication or substance.From 18 Years to 65 Years
Countries
United States
Sponsor
Jina Pharmaceuticals Inc.
Condition
Bipolarity
Other study type icon
CompletedNCT01244490

Extended-release Guanfacine Hydrochloride for ADHD

This study is completed in the United States, in France, in Canada, .... It is testing Extended-release Guanfacine Hydrochloride for ADHD.

Multiple locations, including San Diego
ADHDOtherFrom 6 Years to 17 Years
Countries
United States, France, Canada, ...
Sponsor
Shire
Condition
ADHD
Other study type icon
CompletedNCT00741598

Galantamine for Bipolarity

This study is completed in the United States. It is testing galantamine for Bipolarity.

Multiple locations, including Boston
BipolarityOtherFrom 18 Years to 65 Years
Countries
United States
Sponsor
Icahn School of Medicine at Mount Sinai
Condition
Bipolarity
Other study type icon
CompletedNCT00254202

Iloperidone Compared With Placebo and Active Control for schizophrenia

This study is completed in the United States and in India. It is testing iloperidone Compared With Placebo and Active Control for schizophrenia.

Multiple locations, including Little Rock
SchizophreniaOtherFrom 18 Years to 65 Years
Countries
United States, India
Sponsor
Vanda Pharmaceuticals
Condition
Schizophrenia
Other study type icon
CompletedNCT00735371

Lisdexamfetamine Dimesylate (LDX) for ADHD

This study is completed in the United States. It is testing Lisdexamfetamine Dimesylate (LDX) for ADHD.

Multiple locations, including Little Rock
ADHDOtherFrom 13 Years to 17 Years
Countries
United States
Sponsor
Shire
Condition
ADHD
Other study type icon
TerminatedNCT00771134

Lu AA39959 for depression in bipolarity

This study has public registry information in the United States. It is testing Lu AA39959 for depression in bipolarity.

In Atlanta
Bipolarity, DepressionOtherFrom 18 Years to 65 Years
Countries
United States
Sponsor
H. Lundbeck A/S
Condition
Bipolarity, Depression
Drug study icon
CompletedNCT01239030

Methylphenidate HCl ER Capsules for ADHD

This study is completed in the United States. It is testing Methylphenidate HCl ER Capsules for ADHD.

Multiple locations, including Little Rock
ADHDOtherFrom 6 Years to 18 Years
Countries
United States
Sponsor
Rhodes Pharmaceuticals, L.P.
Condition
ADHD
Drug study icon
TerminatedNCT04663321

MK-1942 When Added to Stable Antidepressant Therapy for depression

This study has public registry information in the United States. It is testing MK-1942 When Added to Stable Antidepressant Therapy for depression.

Multiple locations, including Birmingham
DepressionOtherFrom 18 Years to 65 Years
Countries
United States
Sponsor
Merck Sharp & Dohme LLC
Condition
Depression